Literature DB >> 21481941

Interleukin-32 expression induced by hepatitis B virus protein X is mediated through activation of NF-κB.

Xingfei Pan1, Hong Cao, Jianxi Lu, Xin Shu, Xiaojia Xiong, Xiaolv Hong, Qihuan Xu, Huifen Zhu, Gang Li, Guanxin Shen.   

Abstract

HBV replicates noncytopathically in hepatocytes, but HBV or proteins encoded by HBV genome could induce cytokines, chemokines expression by hepatocytes. Moreover, liver damage in patients with HBV infection is immune-mediated and cytokines play important roles in immune-mediated liver damage after HBV infection. Interleukin-32 (IL-32) is a proinflammatory cytokine and plays a critical role in inflammation. However, the role of HBV in IL-32 expression remains unclear. In the present study, we demonstrate that hepatitis B virus protein X (HBx) increases IL-32 expression through the promoter of IL-32 at positions from -746 to +25 and in a dose-dependent manner. Furthermore, we demonstrate that increase of NF-κB subunits p65 and p50 in Huh7 cells also augments IL-32 expression, and the NF-κB inhibitor blocks the effect of HBx on IL-32 induction. These results indicate that NF-κB activation is required for HBx-induced IL-32 expression. In conclusion, IL-32 is induced by HBx in Huh7 cells. Our results suggest that IL-32 might play an important role in inflammatory response after HBV infection.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21481941     DOI: 10.1016/j.molimm.2011.03.012

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  19 in total

1.  Up-regulation of IL-12 expression in patients with chronic hepatitis B is mediated by the PI3K/Akt pathway.

Authors:  Hong-wei Wang; Hai-li Gao; Xiao-xia Wei; Xin-hong Wang
Journal:  Mol Cell Biochem       Date:  2015-06-11       Impact factor: 3.396

2.  Maintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway.

Authors:  Kun-Yi Lai; Ya-Ching Chou; Jiun-Han Lin; Yi Liu; Kai-Min Lin; Shin-Lian Doong; Mei-Ru Chen; Te-Huei Yeh; Sue-Jane Lin; Ching-Hwa Tsai
Journal:  J Virol       Date:  2015-03-25       Impact factor: 5.103

3.  IL-32 promotes angiogenesis.

Authors:  Claudia A Nold-Petry; Ina Rudloff; Yvonne Baumer; Menotti Ruvo; Daniela Marasco; Paolo Botti; Laszlo Farkas; Steven X Cho; Jarod A Zepp; Tania Azam; Hannah Dinkel; Brent E Palmer; William A Boisvert; Carlyne D Cool; Laima Taraseviciene-Stewart; Bas Heinhuis; Leo A B Joosten; Charles A Dinarello; Norbert F Voelkel; Marcel F Nold
Journal:  J Immunol       Date:  2013-12-11       Impact factor: 5.422

4.  Role of interleukin-32 in Helicobacter pylori-induced gastric inflammation.

Authors:  Kosuke Sakitani; Yoshihiro Hirata; Yoku Hayakawa; Takako Serizawa; Wachiko Nakata; Ryota Takahashi; Hiroto Kinoshita; Kei Sakamoto; Hayato Nakagawa; Masao Akanuma; Haruhiko Yoshida; Shin Maeda; Kazuhiko Koike
Journal:  Infect Immun       Date:  2012-08-13       Impact factor: 3.441

5.  IL-32γ promotes integrin αvβ6 expression through the activation of NF-κB in HSCs.

Authors:  Hongcan Liu; Xingfei Pan; Hong Cao; Xin Shu; Haixia Sun; Jianxi Lu; Jiayin Liang; Ka Zhang; Fengqin Zhu; Gang Li; Qi Zhang
Journal:  Exp Ther Med       Date:  2017-08-17       Impact factor: 2.447

6.  Expression of cytokines in mouse hepatitis B virus X gene-transfected model.

Authors:  Li-Fang Sun; Chuan Shi; Lu Yuan; Yun Sun; Xin-Xin Yao; Jing-Wei Ma; Chun-Mei Huang; Hui-Fen Zhu; Ping Lei; Guan-Xin Shen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-04-17

7.  Enhanced susceptibility to lipopolysaccharide-induced arthritis and endotoxin shock in interleukin-32 alpha transgenic mice through induction of tumor necrosis factor alpha.

Authors:  Masanori Nakayama; Yasuo Niki; Toshiki Kawasaki; Yuki Takeda; Keisuke Horiuchi; Aya Sasaki; Yasunori Okada; Kazuo Umezawa; Hiroyasu Ikegami; Yoshiaki Toyama; Takeshi Miyamoto
Journal:  Arthritis Res Ther       Date:  2012-05-21       Impact factor: 5.156

8.  Inhibition of hepatitis B virus and induction of hepatoma cell apoptosis by ASGPR-directed delivery of shRNAs.

Authors:  Jingwei Ma; Chunmei Huang; Xinxin Yao; Chuan Shi; Lifang Sun; Lu Yuan; Ping Lei; Huifen Zhu; Hongbo Liu; Xiongwen Wu; Qin Ning; Chun Zhou; Guanxin Shen
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

9.  The expression of interleukin-32 is activated by human cytomegalovirus infection and down regulated by hcmv-miR-UL112-1.

Authors:  Yujing Huang; Ying Qi; Yanping Ma; Rong He; Yaohua Ji; Zhengrong Sun; Qiang Ruan
Journal:  Virol J       Date:  2013-02-12       Impact factor: 4.099

10.  Human hepatocytes express absent in melanoma 2 and respond to hepatitis B virus with interleukin-18 expression.

Authors:  Xingfei Pan; Haixia Xu; Changlong Zheng; Mei Li; Xiaofang Zou; Hong Cao; Qihuan Xu
Journal:  Virus Genes       Date:  2016-04-19       Impact factor: 2.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.